Outpace Bio
Seattle, US · 10 known investors
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
Founders & leadership
ML
Marc LajoieCo-founder & Chief Executive Officer
SB
Scott BoykenCo-founder & Chief Technology Officer
SR
Stanley RiddellCo-Founder and Scientific Advisor
Investors · 10
Artis Ventures✓ verifiedSan Francisco · $50K – $25M
RA Capital✓ verifiedBoston
Abstract VenturesSan Francisco
Atinum Investment Co. Ltd.Seoul · $100K – $2M
Civilization Ventures Management, LlcTiburon · $1M – $10M
Modi VenturesHouston
Playground GlobalPalo Alto · $1M – $20M
AbstractreportedSan Francisco · $250K – $750K
Abstract VenturesreportedSan Francisco · $100K – $1M
Playground GlobalreportedPalo Alto